EXIM Matters: Funding technology transfer for vax better than IPR waiver ...Middle East

Business Standard - Economy
EXIM Matters: Funding technology transfer for vax better than IPR waiver
Experts say merely waiving IPR will not raise vaccine supply unless pharma companies transfer the technology and trade secrets that will enable others to produce the vaccines

Hence then, the article about exim matters funding technology transfer for vax better than ipr waiver was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EXIM Matters: Funding technology transfer for vax better than IPR waiver )

Apple Storegoogle play

Last updated :

Also on site :